Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21597 | 25195550 | J Hepatol | Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. | 2014 | Details |
| A21599 | 25195547 | J Hepatol | Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial. | 2014 | Details |
| A21602 | 25194181 | Best Pract Res Clin Gastroenterol | Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. | 2014 | Details |
| A21608 | 25190263 | Dig Dis Sci | Gaps in recognition and evaluation of incidentally identified hepatic steatosis. | 2014 | Details |
| A21613 | 25186086 | Aliment Pharmacol Ther | Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. | 2014 | Details |
| A21618 | 25183341 | Trends Endocrinol Metab | Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD. | 2014 | Details |
| A21628 | 25170559 | Digestion | Can serum pin1 level be regarded as an indicative marker of nonalcoholic steatohepatitis and fibrotic stages? | 2014 | Details |
| A21630 | 25168691 | J Gastroenterol Hepatol | Use of non-invasive serum glycan markers to distinguish non-alcoholic steatohepatitis from simple steatosis. | 2015 | Details |
| A21633 | 25165040 | Hepatol Res | Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease. | 2014 | Details |
| A21640 | 25163357 | Hepatol Res | Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease. | 2014 | Details |
| A21644 | 25156535 | Mol Biol Rep | HLA DQB1 alleles are related with nonalcoholic fatty liver disease. | 2014 | Details |
| A21652 | 25152587 | World J Gastroenterol | Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future. | 2014 | Details |
| A21655 | 25145976 | Hepatol Res | Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications. | 2014 | Details |
| A21656 | 25145655 | Toxicol Sci | Systems level metabolic phenotype of methotrexate administration in the context of non-alcoholic steatohepatitis in the rat. | 2014 | Details |
| A21657 | 25145475 | Hepatology | The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease. | 2014 | Details |
| A21671 | 25134788 | Gut | Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. | 2014 | Details |
| A21677 | 25126490 | Springerplus | Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A21678 | 25126183 | Int J Clin Exp Med | Serum endocan levels in patients with chronic liver disease. | 2014 | Details |
| A21681 | 25125077 | Hepatology | Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. | 2015 | Details |
| A21683 | 25122558 | FASEB J | Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis. | 2014 | Details |
| A21684 | 25121996 | Endocrinology | Repair-related activation of hedgehog signaling in stromal cells promotes intrahepatic hypothyroidism. | 2014 | Details |
| A21685 | 25121514 | PLoS One | The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease. | 2014 | Details |
| A21694 | 25114474 | Indian J Surg Oncol | Steatohepatitic hepatocellular carcinoma-a case report with literature review. | 2014 | Details |
| A21695 | 25112833 | J Endocrinol | Perinatal exposure to bisphenol A exacerbates nonalcoholic steatohepatitis-like phenotype in male rat offspring fed on a high-fat diet. | 2014 | Details |
| A21696 | 25111713 | PLoS One | Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis. | 2014 | Details |
| A21700 | 25110437 | World J Gastroenterol | Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease. | 2014 | Details |
| A21708 | 25103310 | Hepatology | Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. | 2014 | Details |
| A21709 | 25102981 | Dig Dis Sci | Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21719 | 25093717 | Int J Mol Sci | Cystic fibrosis related liver disease--another black box in hepatology. | 2014 | Details |
| A21727 | 25088269 | Curr Pediatr Rev | Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us? | 2014 | Details |
| A21733 | 25083607 | Gastroenterology | Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. | 2014 | Details |
| A21734 | 25083081 | World J Gastroenterol | Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease. | 2014 | Details |
| A21735 | 25083080 | World J Gastroenterol | Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? | 2014 | Details |
| A21738 | 25083077 | World J Gastroenterol | Translational approaches: from fatty liver to non-alcoholic steatohepatitis. | 2014 | Details |
| A21739 | 25083076 | World J Gastroenterol | Role of liver biopsy in nonalcoholic fatty liver disease. | 2014 | Details |
| A21746 | 25073966 | Pediatr Obes | The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children. | 2014 | Details |
| A21747 | 25073669 | Korean J Gastroenterol | [Comparison on the efficacy and safety of biphenyl dimethyl dicarboxylate and ursodeoxycholic acid in patients with abnormal alanine aminotransferase: multicenter, double-blinded, randomized, active-controlled clinical trial]. | 2014 | Details |
| A21756 | 25069572 | Dig Dis Sci | Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea. | 2014 | Details |
| A21757 | 25068001 | World J Hepatol | CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2014 | Details |
| A21768 | 25060399 | J Dig Dis | Progression of liver disease in non-alcoholic fatty liver disease: a prospective clinicopathological follow-up study. | 2014 | Details |
| A21769 | 25060337 | Sci Rep | Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. | 2014 | Details |
| A21774 | 25053716 | Gut | Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. | 2014 | Details |
| A21779 | 25050550 | PLoS Med | Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. | 2014 | Details |
| A21780 | 25048953 | J Hepatol | Cyclophilin inhibition as potential therapy for liver diseases. | 2014 | Details |
| A21785 | 25045618 | Curr Hepatol Rep | Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis. | 2014 | Details |
| A21787 | 25045276 | Clin Exp Gastroenterol | Molecular pathways in non-alcoholic fatty liver disease. | 2014 | Details |
| A21791 | 25043514 | Hepatology | Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. | 2014 | Details |
| A21794 | 25040931 | Hepatol Res | Measurement of liver stiffness as a non-invasive method for diagnosis of non-alcoholic fatty liver disease. | 2014 | Details |
| A21796 | 25040043 | Liver Int | microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. | 2014 | Details |
| A21797 | 25039333 | J Gastroenterol Hepatol | Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | 2014 | Details |
| A21803 | 25034292 | Dig Dis | Non-alcoholic fatty liver disease: diagnosis and investigation. | 2014 | Details |
| A21805 | 25034283 | Dig Dis | The inflammasome in liver injury and non-alcoholic fatty liver disease. | 2014 | Details |
| A21814 | 25028077 | Transl Res | Obesity and the liver: nonalcoholic fatty liver disease. | 2014 | Details |
| A21817 | 25024607 | World J Gastroenterol | High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. | 2014 | Details |
| A21820 | 25024596 | World J Gastroenterol | Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment. | 2014 | Details |
| A21821 | 25024595 | World J Gastroenterol | Experimental models of non-alcoholic fatty liver disease in rats. | 2014 | Details |
| A21824 | 25024592 | World J Gastroenterol | Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis. | 2014 | Details |
| A21826 | 25023045 | Indian J Gastroenterol | Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh. | 2014 | Details |
| A21827 | 25019921 | Dtsch Arztebl Int | Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. | 2014 | Details |
| A21830 | 25018867 | Frontline Gastroenterol | Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. | 2013 | Details |
| A21838 | 25011936 | Gut | Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |
| A21839 | 25009583 | Exp Ther Med | Evaluation of fatty liver fibrosis in rabbits using real-time shear wave elastography. | 2014 | Details |
| A21844 | 25004910 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic. | 2014 | Details |
| A21851 | 25002154 | Gastroenterol Rep (Oxf) | Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease. | 2014 | Details |
| A21854 | 24998389 | Sci Rep | Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model. | 2014 | Details |
| A21857 | 24995693 | Hepatology | The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice. | 2014 | Details |
| A21876 | 24986741 | J Transl Med | Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice. | 2014 | Details |
| A21879 | 24983359 | PLoS One | L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway. | 2014 | Details |
| A21880 | 24983336 | Med Sci Sports Exerc | Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training. | 2015 | Details |
| A21882 | 24978903 | Nat Commun | TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A21884 | 24978432 | Cancers (Basel) | Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs). | 2014 | Details |
| A21885 | 24977111 | Curr Hepatol Rep | Hepatic steatosis and steatohepatitis: Are they really two distinct entities? | 2014 | Details |
| A21889 | 24976563 | Hepatol Res | Influence of lifestyle-related diseases and age on the development and progression of non-alcoholic fatty liver disease. | 2014 | Details |
| A21891 | 24976401 | Biochem Biophys Res Commun | NHE1 deficiency in liver: implications for non-alcoholic fatty liver disease. | 2014 | Details |
| A21898 | 24974878 | Ann Gastroenterol | Insulin resistance in euglycemic cirrhosis. | 2014 | Details |
| A21909 | 24968200 | Br J Nutr | Beneficial effects of soluble dietary Jerusalem artichoke (Helianthus tuberosus) in the prevention of the onset of type 2 diabetes and non-alcoholic fatty liver disease in high-fructose diet-fed rats. | 2014 | Details |
| A21911 | 24966609 | World J Gastroenterol | Radiologic evaluation of nonalcoholic fatty liver disease. | 2014 | Details |
| A21915 | 24966605 | World J Gastroenterol | Pediatric fatty liver disease: role of ethnicity and genetics. | 2014 | Details |
| A21919 | 24966597 | World J Gastroenterol | Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. | 2014 | Details |
| A21920 | 24966582 | World J Gastroenterol | Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen. | 2014 | Details |
| A21923 | 24963148 | EMBO Mol Med | A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. | 2014 | Details |
| A21927 | 24961607 | Liver Transpl | Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. | 2014 | Details |
| A21937 | 24952996 | Neurogastroenterol Motil | Damage to enteric neurons occurs in mice that develop fatty liver disease but not diabetes in response to a high-fat diet. | 2014 | Details |
| A21938 | 24952382 | Lipids Health Dis | Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile. | 2014 | Details |
| A21947 | 24946279 | J Hepatol | ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis. | 2014 | Details |
| A21950 | 24944472 | World J Gastroenterol | Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. | 2014 | Details |
| A21951 | 24943967 | Eur Rev Med Pharmacol Sci | High sensitive CRP and pentraxine 3 as noninvasive biomarkers of nonalcoholic fatty liver disease. | 2014 | Details |
| A21952 | 24941342 | Molecules | Standardized Salvia miltiorrhiza extract suppresses hepatic stellate cell activation and attenuates steatohepatitis induced by a methionine-choline deficient diet in mice. | 2014 | Details |
| A21960 | 24930437 | Liver Int | Keratins 8 and 18 are type II acute-phase responsive genes overexpressed in human liver disease. | 2014 | Details |
| A21967 | 24927058 | Expert Rev Mol Diagn | Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease. | 2014 | Details |
| A21971 | 24923704 | Liver Int | High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census. | 2014 | Details |
| A21980 | 24917551 | Gut | Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. | 2014 | Details |
| A21982 | 24916329 | J Magn Reson Imaging | Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide. | 2014 | Details |
| A21992 | 24905085 | Liver Int | Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |
| A21998 | 24901254 | PLoS One | Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation. | 2014 | Details |
| A22005 | 24898917 | Histopathology | Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients. | 2014 | Details |
| A22006 | 24897026 | Int J Mol Sci | Steatosis and steatohepatitis: complex disorders. | 2014 | Details |
| A22012 | 24890441 | Am J Gastroenterol | Nonalcoholic fatty liver disease is underrecognized in the primary care setting. | 2014 | Details |
| A22018 | 24884574 | BMC Gastroenterol | Fast food diet with CCl4 micro-dose induced hepatic-fibrosis--a novel animal model. | 2014 | Details |
| A22025 | 24868324 | World J Hepatol | Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges? | 2014 | Details |